Case report of amiodarone-associated allergic pneumonitis amidst the COVID-19 pandemic
Amiodarone is a common antiarrhythmic drug that is utilised in clinical practice and is associated with pulmonary toxicity. The most common form of pulmonary complication is interstitial pneumonitis which is treated with discontinuation of amiodarone and initiation of corticosteroids. Amiodarone-...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
IMR Press
2021-03-01
|
| Series: | Reviews in Cardiovascular Medicine |
| Subjects: | |
| Online Access: | https://rcm.imrpress.com/fileup/2153-8174/PDF/1617068689998-482696708.pdf |
| _version_ | 1818500174513700864 |
|---|---|
| author | Meor Azraai Marcus McMahon Ronald Dick |
| author_facet | Meor Azraai Marcus McMahon Ronald Dick |
| author_sort | Meor Azraai |
| collection | DOAJ |
| description | Amiodarone is a common antiarrhythmic drug that is utilised in clinical practice
and is associated with pulmonary toxicity. The most common form of pulmonary
complication is interstitial pneumonitis which is treated with discontinuation of
amiodarone and initiation of corticosteroids. Amiodarone-induced pulmonary
eosinophilia is a rare complication of amiodarone therapy, with blood and
pulmonary eosinophilia the predominant features. During the COVID-19 era, the
incidence of delay in treatment of pulmonary pathology is also delayed due to the
effort of excluding COVID-19 infection. Here we report a case of a 64-year-old man who developed eosinophilic pneumonia
after initiation of amiodarone therapy, and the investigations required to
exclude other forms of pulmonary toxicity. We also reviewed the effect of
COVID-19 testing in the management of patients presenting with respiratory
distress. |
| first_indexed | 2024-12-10T20:39:17Z |
| format | Article |
| id | doaj.art-80c750096f244723a22f49a1003cc1df |
| institution | Directory Open Access Journal |
| issn | 2153-8174 |
| language | English |
| last_indexed | 2024-12-10T20:39:17Z |
| publishDate | 2021-03-01 |
| publisher | IMR Press |
| record_format | Article |
| series | Reviews in Cardiovascular Medicine |
| spelling | doaj.art-80c750096f244723a22f49a1003cc1df2022-12-22T01:34:26ZengIMR PressReviews in Cardiovascular Medicine2153-81742021-03-0122118118410.31083/j.rcm.2021.01.2671617068689998-482696708Case report of amiodarone-associated allergic pneumonitis amidst the COVID-19 pandemicMeor Azraai0Marcus McMahon1Ronald Dick2Department of Cardiology, Epworth Healthcare, Melbourne, 3121 Victoria, AustraliaDepartment of Respiratory Medicine, Epworth Healthcare, Melbourne, 3121 Victoria, AustraliaDepartment of Cardiology, Epworth Healthcare, Melbourne, 3121 Victoria, AustraliaAmiodarone is a common antiarrhythmic drug that is utilised in clinical practice and is associated with pulmonary toxicity. The most common form of pulmonary complication is interstitial pneumonitis which is treated with discontinuation of amiodarone and initiation of corticosteroids. Amiodarone-induced pulmonary eosinophilia is a rare complication of amiodarone therapy, with blood and pulmonary eosinophilia the predominant features. During the COVID-19 era, the incidence of delay in treatment of pulmonary pathology is also delayed due to the effort of excluding COVID-19 infection. Here we report a case of a 64-year-old man who developed eosinophilic pneumonia after initiation of amiodarone therapy, and the investigations required to exclude other forms of pulmonary toxicity. We also reviewed the effect of COVID-19 testing in the management of patients presenting with respiratory distress.https://rcm.imrpress.com/fileup/2153-8174/PDF/1617068689998-482696708.pdfamiodaronepulmonary eosinophiliacovid-19amiodarone-induced pulmonary toxicitycorticosteroids |
| spellingShingle | Meor Azraai Marcus McMahon Ronald Dick Case report of amiodarone-associated allergic pneumonitis amidst the COVID-19 pandemic Reviews in Cardiovascular Medicine amiodarone pulmonary eosinophilia covid-19 amiodarone-induced pulmonary toxicity corticosteroids |
| title | Case report of amiodarone-associated allergic pneumonitis amidst the COVID-19 pandemic |
| title_full | Case report of amiodarone-associated allergic pneumonitis amidst the COVID-19 pandemic |
| title_fullStr | Case report of amiodarone-associated allergic pneumonitis amidst the COVID-19 pandemic |
| title_full_unstemmed | Case report of amiodarone-associated allergic pneumonitis amidst the COVID-19 pandemic |
| title_short | Case report of amiodarone-associated allergic pneumonitis amidst the COVID-19 pandemic |
| title_sort | case report of amiodarone associated allergic pneumonitis amidst the covid 19 pandemic |
| topic | amiodarone pulmonary eosinophilia covid-19 amiodarone-induced pulmonary toxicity corticosteroids |
| url | https://rcm.imrpress.com/fileup/2153-8174/PDF/1617068689998-482696708.pdf |
| work_keys_str_mv | AT meorazraai casereportofamiodaroneassociatedallergicpneumonitisamidstthecovid19pandemic AT marcusmcmahon casereportofamiodaroneassociatedallergicpneumonitisamidstthecovid19pandemic AT ronalddick casereportofamiodaroneassociatedallergicpneumonitisamidstthecovid19pandemic |